BPC 157 + TB 500

Summary

The BPC-157 + TB-500 blend is being investigated for its role in soft tissue, tendon, and musculoskeletal system repair. It combines two of the most studied regenerative peptides in a single vial and is one of the most popular combinations in its field.

What is it being investigated for?

• •  Soft tissue and tendon repair
• •  Musculoskeletal system recovery
• •  Angiogenesis and cytoprotection
• •  Cell migration and inflammation modulation

Cycle and Rest

Mechanism of Action

BPC-157 — Cytoprotection and Angiogenesis

Pentadecapeptide derived from a gastric protein, studied for accelerating healing and protecting the gastrointestinal tract through the VEGFR2 pathway and the FAK-paxillin cascade.

TB-500 — Cell Migration and Repair

Active fraction of thymosin beta-4 that regulates actin and directs the migration of reparative cells to the injury, also modulating inflammation.

Regenerative Synergy

Combined, they address two complementary fronts: angiogenesis and cytoprotection (BPC-157) and cell migration and cytoskeleton remodeling (TB-500).

Scientific Evidence

BPC-157: numerous animal models describe accelerated healing of tendons, muscles, bones, and intestines.

TB-500: thymosin beta-4 has advanced to clinical trials for wound healing and cardiac repair.

Synergy: preclinical models of musculoskeletal recovery support combined use. Honest note: there are no controlled human studies of the combined formulation.

Product Use

This blend combines two complementary repair mechanisms in a single reference material for in vitro and laboratory research. At Peptido BioGenetic, we offer it with high-purity components and a certificate of analysis (COA) available upon request.

⚠️ Product intended exclusively for research and laboratory use. Not for human or veterinary consumption.